{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:10:03Z","timestamp":1790428203872,"version":"4.1.0"},"reference-count":53,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Aim<\/jats:bold>\n                    : Cushing\u2019s syndrome (CS) is associated with weight gain and extreme central, visceral, abdominal obesity which is confirmed with dual-energy X-rays absorptiometric (DXA) diagnostic cut-off point (CP) values of central obesity indexes (COI), determined as an android to gynoid tissue and fat mass ratios. These best differentiate CS from non-CS obese women matched with CS according to their age and BMI. The aim of this study was to determine the CP values of new DXA indexes of central, abdominal obesity as a ratio of android and trunk to legs as well as trunk and legs to total tissue and fat mass that best differentiate CS and matched non-CS obese women in order to confirm central abdominal obesity, and to determine their normal CP values that best differentiate healthy non-obese women from CS and non-CS obese women, and to exclude abdominal obesity completely.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Material and Methods<\/jats:bold>\n                    : DXA indexes of abdominal obesity, calculated as \u0430 ratio of regional body fat and tissue mass compartments android to legs (A\/L), trunk to legs (Tr\/L), trunk to total (Tr\/To) and legs to total (L\/To) values were determined among 4 groups. Each group consisted of 18 women: 1\n                    <jats:sup>st<\/jats:sup>\n                    group of CS, 2\n                    <jats:sup>nd<\/jats:sup>\n                    group of obese women (O\n                    <jats:sub>1<\/jats:sub>\n                    ) not different according to their age and BMI from CS, 3\n                    <jats:sup>rd<\/jats:sup>\n                    group of obese women (O\n                    <jats:sub>2<\/jats:sub>\n                    ) with higher BMI of 35 \u00b1 1.2 kg and a 4\n                    <jats:sup>th<\/jats:sup>\n                    group of non-obese, healthy women (C) with a normal BMI. Diagnostic accuracy (DG) of CP values of DXA indexes of abdominal obesity and indexes of normal body fat distribution (BFD) were determined.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : A\/L, Tr\/L, Tr\/To, and L\/To DXA indexes were significantly different between CS and O\n                    <jats:sub>1<\/jats:sub>\n                    as well as between non-CS women O\n                    <jats:sub>2<\/jats:sub>\n                    compared to O\n                    <jats:sub>1<\/jats:sub>\n                    and C. These indexes had a highly significant correlation among each other and also in relation to their BMI (p &lt; 0.0001). A\/L-Tm CP value of 0.3 best differentiated the CS from group O\n                    <jats:sub>1<\/jats:sub>\n                    , with the highest DG of 100 % and an A\/L-Fm CP value of 0.26 differentiated them with a DG of 94.44% and sensitivity of 100 %. An A\/L-Tn CP value of 0.23 and an A\/L-Fn CP value of 0.25 best differentiated CS and C as well as O\n                    <jats:sub>2<\/jats:sub>\n                    and C for the highest DG of 100 %.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    : DXA indexes A\/L, Tr\/L, Tr\/To and L\/To values were significantly different among the four groups. These values correlated significantly among them and with their BMI in non-CS groups, thus confirming a BMI increase association with a more pronounced abdominal BFD. An A\/L-Tm CP value of 0.3 and an A\/L-Fm CP value of 0.26 were discovered as the best DXA diagnostic indexes of extreme abdominal obesity in CS and these could also be used in discovering abdominal BFD in non-CS obese women with metabolic syndrome (MS). An A\/L-Tn CP value of 0.23 and an A\/L-Fn CP value of 0.25 were discovered as the best DXA diagnostic indexes of normal BFD which completely excluded abdominal obesity.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2021-0020","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T17:54:52Z","timestamp":1635270892000},"page":"37-50","source":"Crossref","is-referenced-by-count":5,"title":["New DXA Diagnostic Indexes of Abdominal Obesity"],"prefix":"10.2478","volume":"42","author":[{"given":"Slavica Shubeska","family":"Stratrova","sequence":"first","affiliation":[{"name":"University Clinic of Endocrinology, Diabetes, and Metabolic Disorders, Faculty of Medicine, University \u201cSts. Cyril and Methodius\u201d , Skopje , R N Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha Jovanovska","family":"Mishevska","sequence":"additional","affiliation":[{"name":"University Clinic of Endocrinology, Diabetes, and Metabolic Disorders, Faculty of Medicine, University \u201cSts. Cyril and Methodius\u201d , Skopje , R N Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljudmila","family":"Efremovska","sequence":"additional","affiliation":[{"name":"Department of MEP Physiology and Anthropology, Faculty of Medicine , University \u201cSts. Cyril and Methodius\u201d , Skopje , N Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Bitoska","sequence":"additional","affiliation":[{"name":"University Clinic of Endocrinology, Diabetes, and Metabolic Disorders, Faculty of Medicine, University \u201cSts. Cyril and Methodius\u201d , Skopje , R N Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Spasovski","sequence":"additional","affiliation":[{"name":"University Clinic of Rheumatology, Faculty of Medicine, University \u201cSts. Cyril and Methodius\u201d , Skopje , N Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"2026071215160199595_j_prilozi-2021-0020_ref_001","doi-asserted-by":"crossref","unstructured":"1. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91: 2906\u20132912.10.1210\/jc.2006-059416735483","DOI":"10.1210\/jc.2006-0594"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_002","doi-asserted-by":"crossref","unstructured":"2. Chanson P, Salenave S. Metabolic Syndrome in Cushing\u2019s Syndrome. Neuroendocrinology. 2010; 92(suppl 1): 96\u2013101.10.1159\/00031427220829627","DOI":"10.1159\/000314272"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_003","doi-asserted-by":"crossref","unstructured":"3. Anagnostis P, Athyros VG, Tziomalos K, et al. Clinical Review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009 Aug; 94(8): 2692\u2013701.10.1210\/jc.2009-037019470627","DOI":"10.1210\/jc.2009-0370"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_004","doi-asserted-by":"crossref","unstructured":"4. Walker BR. Cortisol--cause and Cure for Metabolic Syndrome? Diabet Med. 2006 Dec; 23(12): 1281\u20138.10.1111\/j.1464-5491.2006.01998.x17116176","DOI":"10.1111\/j.1464-5491.2006.01998.x"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_005","doi-asserted-by":"crossref","unstructured":"5. Jessop DS, Dallman MF, Fleming D, at al. Resistance to Glucocorticoid Feedback in Obesity. J Clin Endocrinol Metab. 2001 Sep; 86(91): 4109\u20134114.10.1210\/jcem.86.9.782611549634","DOI":"10.1210\/jcem.86.9.7826"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_006","unstructured":"6. Subeska Stratrova S, Dzikova S, Bogoev M, et al. Functional hypercorticism relations to the metabolic syndrome. BANTAO J. 2005; 3(2): 149\u2013152."},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_007","unstructured":"7. Kyle, Ursula GK, Laurence G, et al. Body composition: what\u2019s new? Curr Opin Clin Nutr Metab Care. 2002 July; 5(4): 427\u2013433."},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_008","doi-asserted-by":"crossref","unstructured":"8. Geer EB, Shen W, Strohmayer E, et al. Body Composition and Cardiovascular Risk Markers after Remission of Cushing\u2019s Disease: A Prospective Study Using Whole-Body MRI. J Clin Endocrinol Metab. 2012; 97:1702\u20131711.10.1210\/jc.2011-3123333989022419708","DOI":"10.1210\/jc.2011-3123"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_009","doi-asserted-by":"crossref","unstructured":"9. Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab. 2007; 292: E654\u2013E667.10.1152\/ajpendo.00453.200617077342","DOI":"10.1152\/ajpendo.00453.2006"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_010","doi-asserted-by":"crossref","unstructured":"10. Neeland IJ, Turer AT, Ayers CR, et al. Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol. 2015 May; 65(19): 2150\u20132151.10.1016\/j.jacc.2015.01.061489046525975481","DOI":"10.1016\/j.jacc.2015.01.061"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_011","doi-asserted-by":"crossref","unstructured":"11. Shuster A, Patlas M, Pinthus JH et al. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012 Jan; 85(1009): 1\u201310.10.1259\/bjr\/38447238347392821937614","DOI":"10.1259\/bjr\/38447238"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_012","doi-asserted-by":"crossref","unstructured":"12. Borga M, West J, Bell JD, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018 Jun; 66(5): 1\u20139.10.1136\/jim-2018-000722599236629581385","DOI":"10.1136\/jim-2018-000722"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_013","doi-asserted-by":"crossref","unstructured":"13. Ulbrich EJ, Nanz D, Leinhard OD, et al. Whole-body adipose tissue and lean muscle volumes and their distribution across gender and age: MR - derived normative values in normal-weight Swiss population. Magn Reson Med. 2018 Jan; 79(1): 449-458.10.1002\/mrm.26676","DOI":"10.1002\/mrm.26676"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_014","doi-asserted-by":"crossref","unstructured":"14. Kaul S, Rothney MP, Peters DM, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring). 2012; 20(6): 1313\u20138.10.1038\/oby.2011.393","DOI":"10.1038\/oby.2011.393"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_015","doi-asserted-by":"crossref","unstructured":"15. Choi YJ, Seo YK, Lee EJ, et al. Quantification of visceral fat using dual-energy x-ray absorptiometry and its reliability according to the amount of visceral fat in Korean adults. J Clin Densitom. 2015 Apr-Jun; 18(2): 192\u20137.10.1016\/j.jocd.2015.02.001","DOI":"10.1016\/j.jocd.2015.02.001"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_016","unstructured":"16. Shubeska Startrova S. Dual-energy x-ray absorptiometry assessment of the body composition in obese women. J Anthropol Soc Serbia (Novi Sad). 2009; 44: 455\u2013461."},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_017","doi-asserted-by":"crossref","unstructured":"17. Neeland IJ, Grundy SM, Li X, et al. Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study. Nutr Diabetes. 2016 Jul; 6(7): e221.10.1038\/nutd.2016.28","DOI":"10.1038\/nutd.2016.28"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_018","doi-asserted-by":"crossref","unstructured":"18. Tiryakioglu O, Ugurlu S, Yalin S, et al. Screening for Cushing\u2019s Syndrome in Obese Patients. Clinics (Sao Paulo). 2010 Jan; 65(1): 9\u201313.10.1590\/S1807-59322010000100003","DOI":"10.1590\/S1807-59322010000100003"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_019","doi-asserted-by":"crossref","unstructured":"19. Ross EJ, Linch DC. Cushing\u2019s syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982 Sep 18; 2(8299): 646\u20139.10.1016\/S0140-6736(82)92749-0","DOI":"10.1016\/S0140-6736(82)92749-0"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_020","doi-asserted-by":"crossref","unstructured":"20. Shubeska Stratrova S, Jovanovska Mishevska S, Bitoska I, et al. Diagnostic central obesity indexes cut-off point values determined with dual-energy X-ray absorptiometry in Cushing\u2019s and obese women. Contributions. 2020; XLI (3): 19\u201327.10.2478\/prilozi-2020-004133500372","DOI":"10.2478\/prilozi-2020-0041"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_021","doi-asserted-by":"crossref","unstructured":"21. M\u00fcller MJ, Geisler C. Defining obesity as a disease. Eur J Clin Nutr. 2017; 71: 1256\u20131258.10.1038\/ejcn.2017.15528952604","DOI":"10.1038\/ejcn.2017.155"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_022","doi-asserted-by":"crossref","unstructured":"22. Vallgarda S, Nielsen MEJ, Hansen AKK, et al. Should Europe follow the US and declare obesity a disease?: a discussion of the so-called utilitarian argument. Eur J Clin Nutr. 2017; 71: 1263\u20131267.10.1038\/ejcn.2017.10328952605","DOI":"10.1038\/ejcn.2017.103"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_023","doi-asserted-by":"crossref","unstructured":"23. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017 Jul; 18(7): 715\u2013723.10.1111\/obr.1255128489290","DOI":"10.1111\/obr.12551"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_024","unstructured":"24. Apovian CM. Obesity: Definition, Comorbidities, Causes, and Burden. Am J Manag Care. 2016 Jun; 22(7 Suppl): s176\u201385."},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_025","doi-asserted-by":"crossref","unstructured":"25. Maggi S, Busetto L, Noale M et al. (2015). Obesity: Definition and epidemiology. In A. Lenzi, S. Migliaccio, & L. M. Donini (Eds.), Multidisciplinary approach to obesity: From assessment to treatment. Cham, Switzerland: Springer International Publishing, pp. 31\u201339.10.1007\/978-3-319-09045-0_3","DOI":"10.1007\/978-3-319-09045-0_3"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_026","doi-asserted-by":"crossref","unstructured":"26. Sharma AM, Campbell-Scherer DL. Redefining obesity: beyond the numbers. Obesity (Silver Spring). 2017 Apr; 25(4): 660\u2013661.10.1002\/oby.2180128349662","DOI":"10.1002\/oby.21801"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_027","doi-asserted-by":"crossref","unstructured":"27. Matsuzawa Y. Obesity and metabolic syndrome: the contribution of visceral fat and adiponectin. Diabetes Management. 2014; 4(4): 391\u2013401.10.2217\/dmt.14.30","DOI":"10.2217\/dmt.14.30"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_028","doi-asserted-by":"crossref","unstructured":"28. Lesser IA, Dick TJ, Guenette JA, et al. The association between cardiorespiratory fitness and abdominal adiposity in postmenopausal, physically inactive South Asian women. Prev Med Rep. 2015 Sep; 2: 783\u2013787.10.1016\/j.pmedr.2015.09.007472141026844150","DOI":"10.1016\/j.pmedr.2015.09.007"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_029","doi-asserted-by":"crossref","unstructured":"29. Neeland IJ, Turer AT, Ayers CR, et al. Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol. 2015; 65(19): 2150\u20132151.10.1016\/j.jacc.2015.01.061489046525975481","DOI":"10.1016\/j.jacc.2015.01.061"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_030","doi-asserted-by":"crossref","unstructured":"30. Broom I. Thinking Around Abdominal Obesity and Cardiovascular Risk. Br J Diabetes Vasc Dis March. 2006; 6(2): 58\u201361.10.1177\/14746514060060020301","DOI":"10.1177\/14746514060060020301"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_031","doi-asserted-by":"crossref","unstructured":"31. Ladeiras-Lopes R, Sampaio F, Bettencourt N, et al. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol (Engl Ed). 2017 May; 70(5): 331\u2013337.10.1016\/j.rec.2016.09.01027765543","DOI":"10.1016\/j.rec.2016.09.010"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_032","doi-asserted-by":"crossref","unstructured":"32. Lopes HF, Correa-Giannella ML, Consolim-Colombo FM, et al. Viseral adiposity syndrome. Diabetol Metab Syndr. 2016; 8(40): B4\u2013B12.10.1186\/s13098-016-0156-2495071027437032","DOI":"10.1186\/s13098-016-0156-2"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_033","doi-asserted-by":"crossref","unstructured":"33. Ibrahim Q, Ahsan M. Measurement of Visceral Fat, Abdominal Circumference and Waist-hip Ratio to Predict Health Risk in Males and Females. Pakistan J Biol Sci. 2019; 22: 168\u2013173.10.3923\/pjbs.2019.168.17331930817","DOI":"10.3923\/pjbs.2019.168.173"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_034","doi-asserted-by":"crossref","unstructured":"34. Rockall AG, Sohaib SA, Evans D, et al. Computed Tomography Assessment of Fat Distribution in Male and Female Patients With Cushing\u2019s Syndrome. Eur J Endocrinol. 2003 Dec; 149(6): 561\u20137.10.1530\/eje.0.149056114640998","DOI":"10.1530\/eje.0.1490561"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_035","doi-asserted-by":"crossref","unstructured":"35. Geer EB, Shen W, Gallagher D, et al. MRI assessment of lean and adipose tissue distribution in female patients with Cushing\u2019s disease. Clin Endocrinol (Oxf). October 2010; 73(4): 469\u2013475.","DOI":"10.1111\/j.1365-2265.2010.03829.x"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_036","doi-asserted-by":"crossref","unstructured":"36. Lee CM, Huxley RR, Wildman RP, et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008; 61: 646\u2013653.10.1016\/j.jclinepi.2007.08.012","DOI":"10.1016\/j.jclinepi.2007.08.012"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_037","doi-asserted-by":"crossref","unstructured":"37. L\u00f6nn L, Kvist H, Ernest I, et al. Changes in body composition and adipose tissue distribution after treatment of women with Cushing\u2019s syndrome. Metabolism. December 1994, 43(12): 1517\u20131522.10.1016\/0026-0495(94)90010-8","DOI":"10.1016\/0026-0495(94)90010-8"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_038","doi-asserted-by":"crossref","unstructured":"38. Kamel EG, McNeill G, Van Wijk MC, et al. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes Relat Metab Disord. 2000; 24: 607\u2013613.10.1038\/sj.ijo.080120410849583","DOI":"10.1038\/sj.ijo.0801204"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_039","doi-asserted-by":"crossref","unstructured":"39. Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord. 2002 Jul; 26(7): 984\u201393.10.1038\/sj.ijo.080196812080454","DOI":"10.1038\/sj.ijo.0801968"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_040","doi-asserted-by":"crossref","unstructured":"40. Brownbill RA, Ilich JZ. Measuring body composition in overweight individuals by dual energy x-ray absorptiometry. BMC Med Imaging. 2005; 5: 1.10.1186\/1471-2342-5-1107984715748279","DOI":"10.1186\/1471-2342-5-1"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_041","doi-asserted-by":"crossref","unstructured":"41. Denton N, Karpe F. Measuring body composition and regional fat mass accurately. Practical diabetes. 2016; 33(7): 224-226.10.1002\/pdi.2043","DOI":"10.1002\/pdi.2043"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_042","doi-asserted-by":"crossref","unstructured":"42. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy X-ray absorptiometry. Am J Clin Nutr. 1995; 61: 274\u2013278.10.1093\/ajcn\/61.2.2747840063","DOI":"10.1093\/ajcn\/61.2.274"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_043","unstructured":"43. Laddu DR, Lee VR, Blew RM, et al. Predicting visceral adipose tissue by MRI using DXA and anthropometry in adolescents and young adults. Int J Body Compos Res. 2012; 10(4): 93\u2013100."},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_044","doi-asserted-by":"crossref","unstructured":"44. Kullberg J, Brandberg J, Angelhed JE, et al. Whole-body adipose tissue analysis: comparison of MRI, CT and dual energy X-ray absorptiometry. Br J Radiol. 2009 Feb; 82(974): 123\u201330.10.1259\/bjr\/8008315619168691","DOI":"10.1259\/bjr\/80083156"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_045","unstructured":"45. Kim JS, Yoo SM, Kim KN, Lee SY. Comparison of DXA and CT for truncal obesity in adult women related to metabolic complications. J Korean Acad Fam Med. 2007 Sep; 28(9): 675\u2013681."},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_046","doi-asserted-by":"crossref","unstructured":"46. Wajchenberg BL, Bosco A, Marone MM, et al. Estimation of body fat and lean tissue distribution by dual energy x-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing\u2019s disease. J Clin Endocrinol Metab. 1995; 80(9): 2791\u20132794.","DOI":"10.1210\/jc.80.9.2791"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_047","doi-asserted-by":"crossref","unstructured":"47. Jebb SA. Measurement of soft tissue composition by dual X-ray absorptiometry. Br J Nutr. 1997; 77(2): 151\u2013163.10.1079\/BJN199700219135364","DOI":"10.1079\/BJN19970021"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_048","doi-asserted-by":"crossref","unstructured":"48. Burt MG, Gibney J, Ho KKY. Characterization of the metabolic phenotypes of Cushing\u2019s syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol (Oxf). 2006 Apr; 64(4): 436\u2013443.10.1111\/j.1365-2265.2006.02488.x16584517","DOI":"10.1111\/j.1365-2265.2006.02488.x"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_049","doi-asserted-by":"crossref","unstructured":"49. Mayo-Smith W, Hayes CW, Biller BM, et al. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology. 1989 Feb; 170(2): 515\u20138.10.1148\/radiology.170.2.29116782911678","DOI":"10.1148\/radiology.170.2.2911678"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_050","doi-asserted-by":"crossref","unstructured":"50. Schafroth UK, Godang K, Ueland T, et al. Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing\u2019s syndrome compared to controls matched for body mass index. J Endocrinol Invest. 2000; 23(6): 349\u2013355.10.1007\/BF0334373710908161","DOI":"10.1007\/BF03343737"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_051","doi-asserted-by":"crossref","unstructured":"51. Garrapa GG, Pantanetti P, Arnaldi G, et al. Body composition and metabolic features in women with adrenal incidentaloma or Cushing\u2019s Syndrome. J Clin Endocrinol Metab. 2001; 86(11): 5301\u20135306.","DOI":"10.1210\/jcem.86.11.8059"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_052","doi-asserted-by":"crossref","unstructured":"52. Salamone LM, Fuerst T, Visser M. Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol. 2000; 89(1): 345\u201352.10.1152\/jappl.2000.89.1.34510904070","DOI":"10.1152\/jappl.2000.89.1.345"},{"key":"2026071215160199595_j_prilozi-2021-0020_ref_053","doi-asserted-by":"crossref","unstructured":"53. Hunter HL, Nagy TR. Body composition in a seasonal model of obesity: longitudinal measures and validation of DXA. Obes Res. 2002 Nov; 10(11): 1180\u20131187.10.1038\/oby.2002.16012429883","DOI":"10.1038\/oby.2002.160"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2021-0020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:01:01Z","timestamp":1783900861000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2021-0020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,10,26]]},"published-print":{"date-parts":[[2021,10,1]]}},"alternative-id":["10.2478\/prilozi-2021-0020"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2021-0020","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}